CEL Historical Financial Ratios
| CVM Stock | USD 0.69 0.05 6.76% |
CEL SCI is presently reporting on over 106 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0025, PTB Ratio of 3.6 or Days Sales Outstanding of 30.68 will help investors to properly organize and evaluate CEL SCI Corp financial condition quickly.
CEL |
About CEL Financial Ratios Analysis
CEL SCI CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate CEL SCI investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on CEL financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across CEL SCI history.
CEL SCI Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing CEL SCI Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on CEL SCI sales, a figure that is much harder to manipulate than other CEL SCI Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from CEL SCI's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into CEL SCI Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At this time, CEL SCI's Dividend Yield is very stable compared to the past year. As of the 16th of December 2024, Inventory Turnover is likely to grow to 1.66, while PTB Ratio is likely to drop 3.60.
| 2023 | 2024 (projected) | Dividend Yield | 0.001687 | 0.002541 | Price To Sales Ratio | 755.03 | 717.28 |
CEL SCI fundamentals Correlations
Click cells to compare fundamentals
CEL SCI Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CEL SCI fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | 23.76 | 7.9 | 4.15 | 4.21 | 3.79 | 3.6 | |
| Book Value Per Share | 0.54 | 1.39 | 0.75 | 0.3 | 0.34 | 0.32 | |
| Free Cash Flow Yield | (0.19) | (0.0598) | (0.0383) | (0.0623) | (0.42) | (0.5) | |
| Operating Cash Flow Per Share | (0.79) | (0.52) | (0.42) | (0.46) | (0.51) | (0.49) | |
| Capex To Depreciation | 1.25 | 4.05 | 0.17 | 0.094 | 0.0846 | 0.0804 | |
| Pb Ratio | 23.76 | 7.9 | 4.15 | 4.21 | 3.79 | 3.6 | |
| Free Cash Flow Per Share | (0.53) | (0.49) | (0.68) | (0.44) | (0.52) | (0.47) | |
| Roic | (1.48) | (0.68) | (1.11) | (2.38) | (2.74) | (2.88) | |
| Inventory Turnover | 0.0218 | 0.25 | 1.94 | 1.76 | 1.58 | 1.66 | |
| Net Income Per Share | (0.88) | (0.96) | (0.89) | (0.73) | (0.65) | (0.69) | |
| Days Of Inventory On Hand | 16.8K | 1.5K | 188.14 | 207.3 | 238.39 | 226.47 | |
| Payables Turnover | 0.008818 | 0.3 | 2.4 | 1.97 | 2.26 | 2.38 | |
| Cash Per Share | 0.42 | 1.04 | 0.53 | 0.0932 | 0.11 | 0.1 | |
| Pocfratio | (30.68) | (23.79) | (7.31) | (2.43) | (2.19) | (2.3) | |
| Interest Coverage | (27.82) | (31.49) | (33.36) | (46.6) | (41.94) | (44.04) | |
| Capex To Operating Cash Flow | (0.18) | (0.48) | (0.0362) | (0.0163) | (0.0187) | (0.0197) | |
| Pfcf Ratio | (26.08) | (16.06) | (7.05) | (2.39) | (2.15) | (2.26) | |
| Days Payables Outstanding | 41.4K | 1.2K | 152.1 | 185.32 | 213.12 | 202.47 | |
| Income Quality | 0.74 | 0.5 | 0.52 | 0.71 | 0.82 | 0.83 | |
| Roe | (1.63) | (0.69) | (1.19) | (2.45) | (2.82) | (2.96) | |
| Ev To Operating Cash Flow | (30.58) | (22.72) | (6.91) | (2.85) | (2.56) | (2.69) | |
| Pe Ratio | (14.54) | (11.4) | (3.48) | (1.72) | (1.55) | (1.62) | |
| Return On Tangible Assets | (0.9) | (0.8) | (0.52) | (0.76) | (1.07) | (0.96) | |
| Ev To Free Cash Flow | (25.99) | (15.34) | (6.66) | (2.8) | (2.52) | (2.65) | |
| Earnings Yield | (0.0688) | (0.0877) | (0.29) | (0.58) | (0.67) | (0.64) | |
| Intangibles To Total Assets | 0.007732 | 0.003636 | 0.0042 | 0.006476 | 0.007448 | 0.007075 | |
| Net Debt To E B I T D A | 0.0586 | 0.59 | 0.23 | (0.34) | (0.39) | (0.37) | |
| Current Ratio | 3.25 | 4.15 | 11.5 | 5.45 | 1.42 | 1.35 | |
| Tangible Book Value Per Share | 0.53 | 1.38 | 0.74 | 0.29 | 0.34 | 0.32 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.63) | Return On Assets (0.61) | Return On Equity (2.50) |
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.